Relive Franchising LLC (AR)

The question every serious investor asks before committing half a million dollars to a franchise is simple: does this brand solve a real, growing, monetizable problem at a price point the market will sustain? In the case of Relive Franchising LLC (AR), the answer begins with a fundamental shift in how Americans think about their own health. Millions of adults between 40 and 70 are actively seeking personalized, preventive, and anti-aging health solutions that fall outside the scope of traditional primary care — services like IV therapy, hormone optimization, peptide therapeutics, and weight management protocols delivered in a clinical but accessible setting. Relive Health was founded in 2017 by Dr. Domenic Iacovone in Stuart, Florida, with an explicit mission to build comprehensive health plans tailored to individual patient symptoms rather than applying one-size-fits-all clinical protocols. That founding thesis has evolved into a nationwide franchise platform now operating across at least six states, with verified open locations in the range of 12 to 25 clinics depending on the data source, and an announced development pipeline targeting over 100 U.S. locations. The leadership team reflects a deliberate mix of clinical authority and franchise operational expertise: Gina Iacovone serves as CEO, while Dr. Eeman Tariq, MD, and Dr. Richard Martinez hold dual Chief Medical Officer positions, and Jerome Kern — co-founder of both OrangeTheory Fitness and Massage Envy — serves as a strategic partner, lending the brand franchise infrastructure credibility that few wellness startups can claim. The Relive Franchising LLC (AR) franchise opportunity sits at the convergence of personalized medicine and scalable retail health, a positioning that makes it among the more strategically interesting franchise concepts entering the market during this decade. This analysis is independent research produced by PeerSense, not marketing copy commissioned by the franchisor.

The industry context surrounding the Relive Franchising LLC (AR) franchise investment opportunity is nothing short of remarkable in terms of sheer market size and directional momentum. The global wellness industry is projected to surpass $9.3 trillion in 2025, and several of the specific service verticals that Relive Health operates within are individually generating multi-billion-dollar growth curves. The global IV therapy market — one of Relive's core service offerings — is projected to expand from $57 billion in 2024 to $74.4 billion by 2029, representing a compound growth rate that reflects surging consumer appetite for direct-to-patient infusion services. The hormone optimization market, another pillar of the Relive service menu, is projected to exceed $35 billion by 2030, driven by an aging baby boomer population, increased awareness of testosterone and estrogen optimization protocols, and a growing body of clinical literature validating these interventions. The global peptide-therapeutics market — encompassing treatments like BPC-157, semaglutide analogs, and growth hormone secretagogues — is on track to reach $260 billion by 2030, a figure that underscores how dramatically consumer and clinical interest in peptide-based health optimization has accelerated. From a competitive dynamics standpoint, the personalized wellness clinic space remains relatively fragmented, with no single dominant national brand having achieved the market saturation that major fitness or urgent care franchises have reached. That fragmentation creates genuine first-mover advantages for franchise investors willing to enter established but not yet crowded markets. Consumer trends reinforcing demand include the mainstreaming of longevity science, the post-pandemic acceleration of health consciousness across all demographics, and the willingness of high-income households to pay out-of-pocket for services that feel both medical and premium. The broader franchise market itself is forecast to grow by $2.24 billion between 2024 and 2029 at a CAGR of 10.8%, while a separate projection estimates the franchise market will expand by $565.5 billion from 2025 to 2030 at a 10% CAGR — reinforcing that franchise as a business format is itself a secular growth vehicle independent of any single category.

The Relive Franchising LLC (AR) franchise cost structure is detailed and reflects the genuine complexity of building out a medical-grade wellness clinic from the ground up. The initial franchise fee is $75,000, which positions this brand at the upper tier of the health and wellness franchise category — a level consistent with concepts that provide differentiated clinical protocols, proprietary systems, and brand equity built on medical credibility rather than fitness trends. The Relive Franchising LLC (AR) franchise investment range spans from a low of approximately $108,700 to a high of $401,000 at the Arkansas-registered entity level, though broader published figures for the full Relive Health model cite total startup investments ranging from $501,000 to $1,053,000, with a separate estimate placing the range at $521,000 to $962,383 — variability driven by clinic size, geographic market, lease terms, and the extent of leasehold improvements required. The leasehold improvement cost alone ranges from $75,000 to as much as $450,000 depending on the condition of the space, while furniture, fixtures, and equipment carry a cost range of $30,000 to $150,000 reflecting the medical and aesthetic equipment required to deliver services at clinical standards. Opening advertising and grand opening marketing budgets are set between $10,000 and $20,000, and initial training and travel expenses range from $5,000 to $50,000. Critically, franchisees should model three months of additional working capital in the range of $40,000 to $180,000 depending on market conditions and ramp-up velocity — a cost center that is frequently underestimated in franchise due diligence. The Relive Franchising LLC (AR) franchise fee structure also includes an ongoing royalty of 6% of monthly gross sales, which is consistent with the health and fitness franchise sector average that typically clusters around that same 6% benchmark. The franchise agreement carries a 10-year term, providing a long operational runway to recapture initial investment and generate cumulative returns. Empire Portfolio Group, an established health and wellness developer and operator that also serves as an area developer for Orangetheory Fitness and partnered with Revelstoke Capital Partners in December 2020, signed a major development agreement with Relive in August 2023, signaling institutional-grade confidence in the brand's scalability and financial model.

Daily operations at a Relive Health clinic center on delivering a rotating menu of evidence-based wellness services — including IV vitamin and hydration therapy, hormone replacement therapy, peptide treatments, aesthetics, and weight management protocols — through a medically supervised, appointment-based model that prioritizes the patient relationship and individualized care planning. The staffing model requires a licensed medical director or supervising physician, nurse practitioners or RNs to deliver clinical services, and front-of-house staff to manage scheduling, member communications, and the guest experience. Kameron Harris leads training and development for the nationwide franchising network, and the formal training program begins with comprehensive instruction at Relive's flagship location in Stuart, Florida, before transitioning to pre-opening training conducted at the franchisee's own newly built-out clinic. The curriculum covers marketing, operations, regulatory compliance, and clinical staffing — acknowledging that a wellness clinic franchise has a fundamentally more complex onboarding process than a food or retail concept. Franchisees receive full integration with Relive's customized online booking and point-of-sale systems, access to a centralized Guest Services center that reduces per-location overhead, and comprehensive operations manuals that codify every aspect of clinic management. Site selection and lease negotiation support is provided by the corporate team, along with complete store design, development, and construction project support — resources that meaningfully de-risk the pre-opening phase for operators without commercial real estate experience. Marketing support covers social media management, public relations, digital marketing strategy, and branded promotional materials, allowing franchise operators to focus on clinical operations rather than building marketing capabilities from scratch. The territory structure includes exclusivity, with the corporate team providing demographic analysis to help franchisees identify markets with the income levels, age distribution, and health consciousness that predict strong clinic performance. The Relive Franchising LLC (AR) franchise model is designed for owner-operators with a genuine interest in health and wellness, though the professional staffing model means that investors with strong management backgrounds can oversee operations without personally delivering clinical services.

Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document for Relive Franchising LLC (AR), which means prospective investors must approach revenue modeling through a combination of publicly reported figures, industry benchmarks, and direct validation with existing franchisees. That said, Relive Health has publicly reported yearly gross sales figures of $1,601,744 per unit, with estimated owner earnings ranging from $240,262 to $320,349 annually — figures that imply pre-expense margins in the 15% to 20% range before accounting for all operating costs, which is broadly consistent with the broader franchise industry's reported average net operating margins of 17% in 2022, with 35% of franchise companies achieving margins of 20% or higher. The Relive Franchising LLC (AR) franchise revenue potential, when evaluated against these figures, suggests a payback period estimated between 3.1 and 5.1 years depending on the specific investment level, clinic ramp trajectory, and local market dynamics — a range that is meaningful for capital planning purposes but requires verification through a franchisee validation process. Investors should note that publicly reported gross sales figures do not account for cost of goods sold, clinical labor, rent, royalties, insurance, or technology fees, all of which must be modeled independently before arriving at a realistic estimate of owner cash flow. The spread between a 3.1-year and 5.1-year payback reflects real operational variability: clinics that achieve strong membership retention, execute grand opening marketing effectively, and staff appropriately during the ramp phase will outperform those that do not. The IV therapy and hormone optimization markets — Relive's core revenue drivers — benefit from a recurring revenue dynamic, with membership and subscription models creating predictable monthly cash flow once a patient base is established. Industry benchmarks suggest that wellness clinics operating in the $1.5 million to $2 million annual revenue range with lean staffing models can generate owner earnings well above the $240,000 floor cited in public materials, though the ceiling is highly market-dependent. Independent prospective franchisees are strongly advised to consult with existing operators, independent accountants familiar with medical franchise economics, and legal counsel before completing investment decisions.

The Relive Franchising LLC (AR) franchise growth trajectory reflects a brand that is still in the early stages of national scaling — a reality that carries both opportunity and execution risk. Open locations have been reported across a range of 12 to 25 clinics as of the most recent available data, operating across at least six states, with Georgia's Chamblee location representing the sixth state milestone reached in February 2024. The Empire Portfolio Group development agreement, signed in August 2023, commits to opening Relive Health clinics in 10 current and new states along the East Coast, Washington D.C., and select Midwest markets — with development commencing in Q4 2023, representing one of the most significant expansion catalysts in the brand's history. The brand's competitive moat is constructed from several reinforcing elements: the clinical credibility provided by dual Chief Medical Officers in Dr. Eeman Tariq and Dr. Richard Martinez, the franchise operational infrastructure contributed by Jerome Kern whose prior co-founding credits include both OrangeTheory Fitness and Massage Envy, and the proprietary care protocols that distinguish Relive from non-medically supervised wellness retail concepts. In a fragmented wellness clinic landscape where most operators are single-location independents or small regional groups, a nationally franchised brand with institutional backing, codified clinical protocols, and a professional training infrastructure occupies a differentiated position that is difficult for independent operators to replicate at scale. The company's mission of creating comprehensive health plans tailored to individual patient symptoms — established by Dr. Domenic Iacovone at the brand's 2017 founding — functions as both a clinical differentiator and a patient retention mechanism, since personalized care plans generate stickier patient relationships than commodity service menus. As the wellness industry continues its trajectory toward a $9.3 trillion global market by 2025, brands that combine clinical credibility with franchise operational systems are positioned to capture disproportionate market share from the fragmented independent clinic sector.

The ideal candidate for the Relive Franchising LLC (AR) franchise opportunity is a business-minded individual with either a background in healthcare, fitness, or wellness services, or strong general management experience with a commitment to assembling and leading a licensed clinical team. The 10-year franchise agreement term signals that this is a long-horizon investment requiring a franchisee with the patience to build a patient membership base over time rather than expecting immediate cash flow from day one. Multi-unit development is clearly anticipated given the Empire Portfolio Group model, which demonstrates that the brand's corporate infrastructure supports operators who want to scale across multiple clinic locations within a defined territory. Available territories are spread across multiple U.S. states with particular development activity along the East Coast, Washington D.C., and select Midwest markets — geographies where household income levels, age demographics, and health-consciousness indices tend to support the price points that wellness clinic services command. The demographic insights analysis provided by the Relive corporate team during site selection is a meaningful resource for operators evaluating markets, as consumer willingness to pay for IV therapy and hormone optimization services correlates strongly with median household income and population age distribution. Franchisees with clinical backgrounds may find the training curriculum accelerated, while those from business-only backgrounds should budget additional time for familiarization with compliance and clinical staffing dynamics. The timeline from signing to grand opening will vary based on lease negotiation, build-out complexity, and equipment procurement, but the corporate team's involvement in site design and construction project management is designed to compress that timeline as much as market conditions allow.

For investors actively conducting franchise due diligence in the health and wellness sector, the Relive Franchising LLC (AR) franchise represents a strategically compelling opportunity that warrants rigorous, structured evaluation rather than either dismissal or uncritical enthusiasm. The combination of an $9.3 trillion global wellness industry tailwind, service verticals growing at double-digit rates, institutional franchise partners like Empire Portfolio Group, and a founding team with demonstrated clinical and operational credibility creates an investment thesis with genuine substance. The 10-year agreement term, $75,000 franchise fee, 6% royalty structure, and total investment range that can reach over $1 million at the full build-out level means this is a serious capital commitment that demands equally serious due diligence — including direct conversations with existing franchisees, independent financial modeling of unit economics, and legal review of the complete Franchise Disclosure Document. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark the Relive Franchising LLC (AR) franchise cost, revenue, and support structure against competing concepts across the wellness and medical franchise category. The publicly reported gross revenue of $1,601,744 per unit and estimated owner earnings of $240,262 to $320,349 provide a starting point for financial modeling, but the full picture requires the depth of data and analytical frameworks that no single source other than a comprehensive franchise intelligence platform can provide. Explore the complete Relive Franchising LLC (AR) franchise profile on PeerSense to access the full suite of independent franchise intelligence data.